Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative evaluation and patient selection.

Untreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When surgical correction is not feasible due to high operative risk, transcatheter tricuspid valve treatment has been suggested as an attractive value option.